http://www.medpagetoday.com/
John S. Sundy, M.D., Ph.D., Duke in Durham, N.C.

SAN FRANCISCO, Oct. 27 — Severe refractory gout may respond to intravenous infusion of the investigational agent pegl…

Post to Twitter Tweet This Post